Bionano Genomics Announces Positive Outcome of Its Special Stockholder Meeting
September 30, 2020 16:10 ET
|
Bionano Genomics
SAN DIEGO, Sept. 30, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that its stockholders have voted in favor of the company’s proposal to increase the number of its...
Bionano Genomics Announces Continued Expansion of Global Business with Adoption of Saphyr for Next-Generation Cytogenomics in Eastern Europe and Australia
September 29, 2020 17:53 ET
|
Bionano Genomics
SAN DIEGO, Sept. 29, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that its Saphyr system has been adopted through reagent-rental agreements by two renowned...
German Accreditation of Laboratory Developed Tests on Bionano’s Saphyr System Accelerates Utilization in Clinical Diagnostics
September 24, 2020 08:00 ET
|
Bionano Genomics
SAN DIEGO, Sept. 24, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that MVZ Martinsried, a leading clinical diagnostics service provider in Germany, received...
Bionano to Present at the September 2020 Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
September 21, 2020 08:00 ET
|
Bionano Genomics
SAN DIEGO, Sept. 21, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that Erik Holmlin, Ph.D., CEO of Bionano, will present a company overview and be available for...
Bionano Data Provides Understanding of Repeat Expansion Disorders Causing Muscular Dystrophy and ALS
September 17, 2020 08:00 ET
|
Bionano Genomics
SAN DIEGO, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that teams from the Mayo Clinic and from the University of Florida have separately released...
Bionano Genomics Continues to See Expansion in the Adoption of Saphyr for Digital Cytogenetics at Leading Medical Institutions
September 16, 2020 08:00 ET
|
Bionano Genomics
SAN DIEGO, Sept. 16, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that its Saphyr system has been adopted through reagent-rentals by four additional institutions in...
Bionano Genomics Expands Its Diagnostic Testing Menu with Launch of Lineagen’s EpiPanelDx PLUS Gene Panel Test that Identifies Genetic Conditions Related to Epilepsy
September 14, 2020 08:00 ET
|
Bionano Genomics
EpiPanelDx PLUS adds to Lineagen’s expanding menu of diagnostic tests for children with developmental disorders and provides an offering designed specifically for patients that have experienced...
Bionano Genomics Announces Continued Expansion of European Business With Adoption of Saphyr at Three of Europe’s Largest Pediatric Hospitals in Spain, Italy and France
September 10, 2020 08:00 ET
|
Bionano Genomics
SAN DIEGO, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that its Saphyr system has been adopted through reagent-rental agreements by three renowned...
Vertebrate Genome Project Rules Bionano Optical Mapping Technology As Essential Part of Assembling Reference Quality Genomes
September 09, 2020 08:00 ET
|
Bionano Genomics
SAN DIEGO, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that the International Genome 10K (G10K) Consortium selected Bionano optical mapping technology as...
Bionano Genomics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 04, 2020 18:00 ET
|
Bionano Genomics
SAN DIEGO, Sept. 04, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that, in accordance with Nasdaq Listing Rule 5635(c)(4), the Compensation Committee of its Board...